{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:03:20Z","timestamp":1791129800540,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6105","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T14:09:50Z","timestamp":1412690990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity"],"prefix":"10.1038","volume":"5","author":[{"given":"Erwan","family":"Pernet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Lambeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sermet-Gaudelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe C.","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Jeammet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lhousseine","family":"Touqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"BFncomms6105_CR1","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","volume":"183","author":"M Cohen-Cymberknoh","year":"2011","unstructured":"Cohen-Cymberknoh, M., Shoseyov, D. & Kerem, E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am. J. Respir. Crit. Care Med. 183, 1463\u20131471 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFncomms6105_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/CMR.00068-09","volume":"23","author":"JJ Lipuma","year":"2010","unstructured":"Lipuma, J. J. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23, 299\u2013323 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFncomms6105_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B Kerem","year":"1989","unstructured":"Kerem, B. et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073\u20131080 (1989).","journal-title":"Science"},{"key":"BFncomms6105_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan, J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066\u20131073 (1989).","journal-title":"Science"},{"key":"BFncomms6105_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/humu.10041","volume":"19","author":"JL Bobadilla","year":"2002","unstructured":"Bobadilla, J. L., Macek, M. Jr, Fine, J. P. & Farrell, P. M. Cystic fibrosis: a worldwide analysis of CFTR mutations\u2014correlation with incidence data and application to screening. Hum. Mutat. 19, 575\u2013606 (2002).","journal-title":"Hum. Mutat."},{"key":"BFncomms6105_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm.2715","volume":"18","author":"TS Cohen","year":"2012","unstructured":"Cohen, T. S. & Prince, A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18, 509\u2013519 (2012).","journal-title":"Nat. Med."},{"key":"BFncomms6105_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1574-6968.2009.01704.x","volume":"300","author":"AM George","year":"2009","unstructured":"George, A. M., Jones, P. M. & Middleton, P. G. Cystic fibrosis infections: treatment strategies and prospects. FEMS Microbiol. Lett. 300, 153\u2013164 (2009).","journal-title":"FEMS Microbiol. Lett."},{"key":"BFncomms6105_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/CMR.00036-10","volume":"24","author":"AR Hauser","year":"2011","unstructured":"Hauser, A. R., Jain, M., Bar-Meir, M. & McColley, S. A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 24, 29\u201370 (2011).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFncomms6105_CR9","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60011-8","volume":"10","author":"T Pressler","year":"2011","unstructured":"Pressler, T. et al. Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J. Cyst. Fibros. 10, (Suppl 2): S75\u2013S78 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"BFncomms6105_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","volume":"156","author":"DS Armstrong","year":"1997","unstructured":"Armstrong, D. S. et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 156, 1197\u20131204 (1997).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFncomms6105_CR11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1099\/mic.0.2006\/004077-0","volume":"153","author":"F Harrison","year":"2007","unstructured":"Harrison, F. Microbial ecology of the cystic fibrosis lung. Microbiology 153, 917\u2013923 (2007).","journal-title":"Microbiology"},{"key":"BFncomms6105_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1378\/chest.09-0132","volume":"136","author":"S Razvi","year":"2009","unstructured":"Razvi, S. et al. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136, 1554\u20131560 (2009).","journal-title":"Chest"},{"key":"BFncomms6105_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nrmicro2907","volume":"10","author":"A Folkesson","year":"2012","unstructured":"Folkesson, A. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10, 841\u2013851 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms6105_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbalip.2007.12.001","volume":"1781","author":"TJ Nevalainen","year":"2008","unstructured":"Nevalainen, T. J., Graham, G. G. & Scott, K. F. Antibacterial actions of secreted phospholipases A2. Review. Biochim. Biophys. Acta 1781, 1\u20139 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms6105_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/1566524013363258","volume":"1","author":"L Touqui","year":"2001","unstructured":"Touqui, L. & Alaoui-El-Azher, M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1, 739\u2013754 (2001).","journal-title":"Curr. Mol. Med."},{"key":"BFncomms6105_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrmicro976","volume":"2","author":"RI Lehrer","year":"2004","unstructured":"Lehrer, R. I. Primate defensins. Nat. Rev. Microbiol. 2, 727\u2013738 (2004).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms6105_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.biochi.2010.01.024","volume":"92","author":"Y Wu","year":"2010","unstructured":"Wu, Y. et al. Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host. Biochimie 92, 583\u2013587 (2010).","journal-title":"Biochimie"},{"key":"BFncomms6105_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.plipres.2010.12.001","volume":"50","author":"M Murakami","year":"2011","unstructured":"Murakami, M. et al. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog. Lipid Res. 50, 152\u2013192 (2011).","journal-title":"Prog. Lipid Res."},{"key":"BFncomms6105_CR19","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.4049\/jimmunol.175.10.6786","volume":"175","author":"A Piris-Gimenez","year":"2005","unstructured":"Piris-Gimenez, A. et al. In vivo protective role of human group IIa phospholipase A2 against experimental anthrax. J. Immunol. 175, 6786\u20136791 (2005).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI5468","volume":"103","author":"AK Foreman-Wykert","year":"1999","unstructured":"Foreman-Wykert, A. K., Weinrauch, Y., Elsbach, P. & Weiss, J. Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria. J. Clin. Invest. 103, 715\u2013721 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6105_CR21","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1128\/IAI.66.6.2791-2797.1998","volume":"66","author":"XD Qu","year":"1998","unstructured":"Qu, X. D. & Lehrer, R. I. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 66, 2791\u20132797 (1998).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR22","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1021\/bi301140b","volume":"51","author":"RC Oslund","year":"2012","unstructured":"Oslund, R. C. & Gelb, M. H. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates. Biochemistry 51, 8617\u20138626 (2012).","journal-title":"Biochemistry"},{"key":"BFncomms6105_CR23","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/infdis\/jit359","volume":"208","author":"E Movert","year":"2013","unstructured":"Movert, E. et al. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence. J. Infect. Dis. 208, 2025\u20132035 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6105_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbalip.2004.12.012","volume":"1733","author":"TJ Nevalainen","year":"2005","unstructured":"Nevalainen, T. J. et al. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim. Biophys. Acta 1733, 210\u2013223 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms6105_CR25","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1172\/JCI118664","volume":"97","author":"DS Grass","year":"1996","unstructured":"Grass, D. S. et al. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97, 2233\u20132241 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6105_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bbalip.2006.04.002","volume":"1761","author":"LI Eerola","year":"2006","unstructured":"Eerola, L. I. et al. Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim. Biophys. Acta 1761, 745\u2013756 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms6105_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4049\/jimmunol.159.1.391","volume":"159","author":"L Arbibe","year":"1997","unstructured":"Arbibe, L. et al. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 159, 391\u2013400 (1997).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1165\/ajrcmb\/4.4.313","volume":"4","author":"PL Zeitlin","year":"1991","unstructured":"Zeitlin, P. L. et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4, 313\u2013319 (1991).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFncomms6105_CR29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1128\/IAI.73.3.1695-1705.2005","volume":"73","author":"VT Lee","year":"2005","unstructured":"Lee, V. T., Smith, R. S., Tummler, B. & Lory, S. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect. Immun. 73, 1695\u20131705 (2005).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrmicro2199","volume":"7","author":"AR Hauser","year":"2009","unstructured":"Hauser, A. R. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7, 654\u2013665 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFncomms6105_CR31","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1128\/IAI.71.9.5296-5305.2003","volume":"71","author":"CL Rocha","year":"2003","unstructured":"Rocha, C. L., Coburn, J., Rucks, E. A. & Olson, J. C. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect. Immun. 71, 5296\u20135305 (2003).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR32","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1128\/IAI.00489-06","volume":"74","author":"EP O\u2019Grady","year":"2006","unstructured":"O\u2019Grady, E. P., Mulcahy, H., O'Callaghan, J., Adams, C. & O\u2019Gara, F. Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y. Infect. Immun. 74, 5893\u20135902 (2006).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR33","doi-asserted-by":"publisher","first-page":"19890","DOI":"10.1073\/pnas.0606756104","volume":"103","author":"LR Hoffman","year":"2006","unstructured":"Hoffman, L. R. et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 103, 19890\u201319895 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6105_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1099\/00222615-34-4-213","volume":"34","author":"ZA Machan","year":"1991","unstructured":"Machan, Z. A. et al. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance. J. Med. Microbiol. 34, 213\u2013217 (1991).","journal-title":"J. Med. Microbiol."},{"key":"BFncomms6105_CR35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/JB.187.2.554-566.2005","volume":"187","author":"LM Mashburn","year":"2005","unstructured":"Mashburn, L. M., Jett, A. M., Akins, D. R. & Whiteley, M. Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J. Bacteriol. 187, 554\u2013566 (2005).","journal-title":"J. Bacteriol."},{"key":"BFncomms6105_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1574-695X.2011.00820.x","volume":"62","author":"L Yang","year":"2011","unstructured":"Yang, L. et al. Pattern differentiation in co-culture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 62, 339\u2013347 (2011).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFncomms6105_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1388-1981(00)00112-8","volume":"1488","author":"TJ Nevalainen","year":"2000","unstructured":"Nevalainen, T. J., Haapamaki, M. M. & Gronroos, J. M. Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim. Biophys. Acta 1488, 83\u201390 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms6105_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1099\/jmm.0.05303-0","volume":"52","author":"A Dubouix","year":"2003","unstructured":"Dubouix, A. et al. Bactericidal properties of group IIa secreted phospholipase A(2) against Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 52, 1039\u20131045 (2003).","journal-title":"J. Med. Microbiol."},{"key":"BFncomms6105_CR39","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1128\/IAI.01705-07","volume":"76","author":"T Koprivnjak","year":"2008","unstructured":"Koprivnjak, T., Weidenmaier, C., Peschel, A. & Weiss, J. P. Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3. Infect. Immun. 76, 2169\u20132176 (2008).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1006\/bbrc.1995.1388","volume":"208","author":"MD Rosenthal","year":"1995","unstructured":"Rosenthal, M. D. et al. Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem. Biophys. Res. Commun. 208, 650\u2013656 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFncomms6105_CR41","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/iai.64.7.2425-2430.1996","volume":"64","author":"LM Madsen","year":"1996","unstructured":"Madsen, L. M., Inada, M. & Weiss, J. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli. Infect. Immun. 64, 2425\u20132430 (1996).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR42","doi-asserted-by":"publisher","first-page":"L816","DOI":"10.1152\/ajplung.00466.2004","volume":"289","author":"S Medjane","year":"2005","unstructured":"Medjane, S., Raymond, B., Wu, Y. & Touqui, L. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol 289, L816\u2013L824 (2005).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol"},{"key":"BFncomms6105_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mib.2008.12.007","volume":"12","author":"J Engel","year":"2009","unstructured":"Engel, J. & Balachandran, P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12, 61\u201366 (2009).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFncomms6105_CR44","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1128\/IAI.68.5.2916-2924.2000","volume":"68","author":"D Dacheux","year":"2000","unstructured":"Dacheux, D. et al. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect. Immun. 68, 2916\u20132924 (2000).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR45","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1086\/320737","volume":"183","author":"A Roy-Burman","year":"2001","unstructured":"Roy-Burman, A. et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183, 1767\u20131774 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6105_CR46","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell, B. B. & Yang, V. W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90, 1337\u20131381 (2010).","journal-title":"Physiol. Rev."},{"key":"BFncomms6105_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.20031132","volume":"199","author":"S SenBanerjee","year":"2004","unstructured":"SenBanerjee, S. et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199, 1305\u20131315 (2004).","journal-title":"J. Exp. Med."},{"key":"BFncomms6105_CR48","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1073\/pnas.0508235103","volume":"103","author":"H Das","year":"2006","unstructured":"Das, H. et al. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc. Natl Acad. Sci. USA 103, 6653\u20136658 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6105_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1165\/rcmb.2007-0282OC","volume":"38","author":"MT Saavedra","year":"2008","unstructured":"Saavedra, M. T. et al. Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways. Am. J. Respir. Cell Mol. Biol. 38, 679\u2013688 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFncomms6105_CR50","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1128\/IAI.00121-09","volume":"77","author":"K Dach","year":"2009","unstructured":"Dach, K. et al. Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1. Infect. Immun. 77, 5583\u20135592 (2009).","journal-title":"Infect. Immun."},{"key":"BFncomms6105_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.0901798","volume":"185","author":"J Zahlten","year":"2010","unstructured":"Zahlten, J. et al. TLR2- and nucleotide-binding oligomerization domain 2-dependent Kruppel-like factor 2 expression downregulates NF-kappa B-related gene expression. J. Immunol. 185, 597\u2013604 (2010).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR52","doi-asserted-by":"publisher","first-page":"36369","DOI":"10.1074\/jbc.274.51.36369","volume":"274","author":"UM Goehring","year":"1999","unstructured":"Goehring, U. M., Schmidt, G., Pederson, K. J., Aktories, K. & Barbieri, J. T. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J. Biol. Chem. 274, 36369\u201336372 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6105_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4049\/jimmunol.173.1.521","volume":"173","author":"AP Gimenez","year":"2004","unstructured":"Gimenez, A. P. et al. High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J. Immunol. 173, 521\u2013530 (2004).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR54","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1086\/340821","volume":"185","author":"JO Gronroos","year":"2002","unstructured":"Gronroos, J. O., Laine, V. J. & Nevalainen, T. J. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J. Infect. Dis. 185, 1767\u20131772 (2002).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6105_CR55","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.4049\/jimmunol.1100499","volume":"187","author":"E Movert","year":"2011","unstructured":"Movert, E., Wu, Y., Lambeau, G., Touqui, L. & Areschoug, T. A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A. J. Immunol. 187, 6437\u20136446 (2011).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR56","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1172\/JCI117704","volume":"95","author":"SS Harwig","year":"1995","unstructured":"Harwig, S. S. et al. Bactericidal properties of murine intestinal phospholipase A2. J. Clin. Invest. 95, 603\u2013610 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6105_CR57","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1165\/rcmb.2002-0191OC","volume":"28","author":"DJ Weiner","year":"2003","unstructured":"Weiner, D. J., Bucki, R. & Janmey, P. A. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am. J. Respir. Cell. Mol. Biol. 28, 738\u2013745 (2003).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFncomms6105_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcf.2003.12.008","volume":"3","author":"CI Chen","year":"2004","unstructured":"Chen, C. I., Schaller-Bals, S., Paul, K. P., Wahn, U. & Bals, R. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros. 3, 45\u201350 (2004).","journal-title":"J. Cyst. Fibros."},{"key":"BFncomms6105_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11130","volume":"487","author":"AA Pezzulo","year":"2012","unstructured":"Pezzulo, A. A. et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487, 109\u2013113 (2012).","journal-title":"Nature"},{"key":"BFncomms6105_CR60","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1086\/377000","volume":"188","author":"P Berthelot","year":"2003","unstructured":"Berthelot, P. et al. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J. Infect. Dis. 188, 512\u2013518 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFncomms6105_CR61","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1099\/13500872-142-10-2785","volume":"142","author":"I Delic-Attree","year":"1996","unstructured":"Delic-Attree, I., Toussaint, B., Froger, A., Willison, J. C. & Vignais, P. M. Isolation of an IHF-deficient mutant of a Pseudomonas aeruginosa mucoid isolate and evaluation of the role of IHF in algD gene expression. Microbiology 142, (Pt 10): 2785\u20132793 (1996).","journal-title":"Microbiology"},{"key":"BFncomms6105_CR62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4049\/jimmunol.181.1.586","volume":"181","author":"R Ramphal","year":"2008","unstructured":"Ramphal, R. et al. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J. Immunol. 181, 586\u2013592 (2008).","journal-title":"J. Immunol."},{"key":"BFncomms6105_CR63","doi-asserted-by":"publisher","first-page":"22378","DOI":"10.1074\/jbc.270.38.22378","volume":"270","author":"BP Kennedy","year":"1995","unstructured":"Kennedy, B. P. et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270, 22378\u201322385 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFncomms6105_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/gt.2010.28","volume":"17","author":"SM Buff","year":"2010","unstructured":"Buff, S. M. et al. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 17, 567\u2013576 (2010).","journal-title":"Gene Ther."},{"key":"BFncomms6105_CR65","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1126\/science.8310295","volume":"263","author":"CA Vasconcellos","year":"1994","unstructured":"Vasconcellos, C. A. et al. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263, 969\u2013971 (1994).","journal-title":"Science"},{"key":"BFncomms6105_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/thx.50.8.880","volume":"50","author":"T Brandt","year":"1995","unstructured":"Brandt, T., Breitenstein, S., von der Hardt, H. & Tummler, B. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 50, 880\u2013882 (1995).","journal-title":"Thorax"},{"key":"BFncomms6105_CR67","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0005-2736(76)90227-3","volume":"436","author":"J Weiss","year":"1976","unstructured":"Weiss, J., Franson, C., Schmeidler, K. & Elsbach, P. Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction. Biochim. Biophys. Acta 436, 154\u2013169 (1976).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms6105_CR68","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.1996.tb15353.x","volume":"117","author":"M Paya","year":"1996","unstructured":"Paya, M., Terencio, M. C., Ferrandiz, M. L. & Alcaraz, M. J. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br. J. Pharmacol. 117, 1773\u20131779 (1996).","journal-title":"Br. J. Pharmacol."},{"key":"BFncomms6105_CR69","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1183\/09031936.04.00014404","volume":"24","author":"PR Burgel","year":"2004","unstructured":"Burgel, P. R., Cardell, L. O., Ueki, I. F. & Nadel, J. A. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur. Respir. J. 24, 594\u2013600 (2004).","journal-title":"Eur. Respir. J."},{"key":"BFncomms6105_CR70","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1183\/09031936.00164212","volume":"42","author":"C Martin","year":"2013","unstructured":"Martin, C. et al. CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium. Eur. Respir. J. 42, 1553\u20131562 (2013).","journal-title":"Eur. Respir. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:57:07Z","timestamp":1672973827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,23]]}},"alternative-id":["BFncomms6105"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6105","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"assertion":[{"value":"6 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5105"}}